In 1958, against the background of China's Great Leap Forward, the local government of Xuzhou founded Xuzhou Pharmaceutical Factory, a comprehensive pharmaceutical factory in the north of Jiangsu Province, with the initial technical force coming from a group of technicians dispatched to Xuzhou from domestic professional colleges and universities. Our products include eye drops, tablets, tinctures, capsules, raw materials and auxiliary materials.
★ In 1962, after three years of difficulties, like all the pharmaceutical factories in the country, a new phase of merger began. At this time, under the instructions of the government, the merger of "Xuzhou Xinhua Chemical Factory", "Xuzhou Longhai Chemical Factory" and "Xuzhou Chemical Research Institute". This initial merger made the structure of Xuzhou's pharmaceutical industry more complete. Liu Shaoqi, the president of the state at the time, proposed to "trust" the industry, which led to the formation of 11 state-owned pharmaceutical factories in East China. This, together with the national pharmaceutical enterprises***, created a new mode of operation for China's pharmaceutical industry. In an era when demand exceeded supply, this mode of operation played a positive role in solving people's demand for medicines.
★ In 1963, the production of anesthetic ether was started, and Xuzhou Pharmaceutical Factory became one of the only three manufacturers in the country to produce this product, and began to venture into the field of central nervous system drugs. In the 1960s, during the period of resistance to the United States and Vietnam, anesthesia ether, as an important field medical supplies, was one of Xuzhou Pharmaceutical Factory's products applied outside the country.
★ In 1970, the country set off the climax of grasping industry, Xuzhou Pharmaceutical Factory launched the first antibiotic product tetracycline, in the spirit of the national technical collaboration only 72 days to complete the equipment manufacturing, process design, testing and put into production, built an annual output of 20 tons of the production scale, and in a few years to achieve the highest unit of the country's fermentation indicators.
★ In 1972, we launched the chemical synthesis of finasteride, an important product of antipyretic and analgesic drugs, and successfully solved the technical problems of pressurized alkylation, inductive distillation, and the control of organic chlorine, and became one of only a few finasteride production plants in China.
★ In the late seventies, Xuzhou Pharmaceutical Three Plants, which was derived from Xuzhou Pharmaceutical Plant, successively developed psychotropic drugs such as nitrovalerian and clonidine, and began to gradually form a series of products for the central nervous system, and became a national designated manufacturer of psychotropic drugs.
★ In 1995, the trademark "Nhwa Enhua" was registered.
★ In 1996, Xuzhou Enhua Pharmaceutical Group was established with Xuzhou No.3 Pharmaceutical Factory as the core.
★ In 1999, Xuzhou Enhua Pharmaceutical Group Co., Ltd. was established on the basis of Xuzhou No. 3 Pharmaceutical Factory, the core enterprise of Enhua Pharmaceutical Group, after two restructurings.
To date, Enhua Pharmaceutical Group continues to specialize in the production and research and development of central nervous system drugs. The product line covers more than 20 branches of the central nervous system, including antipsychotics, anesthesiologists, antidepressants, anxiolytics, hypnotics, analgesics, anti-migraine, anti-epileptics, central excitants, anti-inflammatory and analgesic drugs, multiple sclerosis drugs, as well as anti-Alzheimer's disease, anti-Parkinson's disease, and more than 40 other drugs. It has become an important production base of central nervous system drugs in China.